<tt id="6hsgl"><pre id="6hsgl"><pre id="6hsgl"></pre></pre></tt>
          <nav id="6hsgl"><th id="6hsgl"></th></nav>
          国产免费网站看v片元遮挡,一亚洲一区二区中文字幕,波多野结衣一区二区免费视频,天天色综网,久久综合给合久久狠狠狠,男人的天堂av一二三区,午夜福利看片在线观看,亚洲中文字幕在线无码一区二区

          Companies

          Bayer HealthCare relocates

          By Liu Jie (China Daily)
          Updated: 2011-03-25 09:44
          Large Medium Small

          Bayer HealthCare relocates

          An advertisement for White and Black, a cold medicine, in a subway station in Beijing. Bayer HealthCare bought the brand in 2006 for 100 million euros ($141 million). [Photo / China Daily] 

          The drugmaker says relocation is scheduled to be completed by June this year

          BEIJING - The pharmaceutical company Bayer HealthCare (BHC) is moving its general medicine headquarters to Beijing, which is a first among multinational drugmakers.

          "We expect this step to speed up the decision-making process and to promote more general efficiency in our day-to-day work," Chris H. Lee, the managing director of BHC China, said on Thursday. "For Chinese patients, the relocation of our general medicine headquarters will allow for more efficient product launches in China and focus greater attention on unmet local medical needs."

          BHC, a subsidiary of Germany's Bayer AG, said the decision to move was made late last year and the relocation is expected to be completed in June of this year.

          Bayer HealthCare relocates

          Chris H. Lee, managing director of BHC China?

          BHC plans to introduce some 20 new products in China over the next five years, including those in the fields of oncology, cardiology, women's healthcare, and diagnostic imaging. Two new products also will be launched this year. The company unveiled four new products and undertook 22 clinical trials in China in 2010.

          Lee said that the increasing importance of the Chinese market and BHC's rapid growth in the country had led to the relocation. The company is one of the top three multinational drugmakers in China, with sales from the business growing above the industry average at 22 percent year-on-year in 2010, according to the independent medical care researcher IMS Health.

          General drugs account for 82 percent of the company's business. In this sector, Chinese sales contribute 12 percent to the global total. "What we do in China will have an effect on other developing economies," Lee said.

          According to IMS Health, China is now the world's third-largest pharmaceutical market, and is predicted to grow between 25 percent and 27 percent to more than $50 billion in 2011.

          In addition to moving its general medicine headquarters, BHC is moving to a regionalized structure by dividing the huge Chinese market into three regions; the central China unit will be based in Beijing, southern China will be controlled from Shanghai, and the operations center for the west of the country will be located in Chengdu.

          "The strategy will enable us to be customer-centric, to disaggregate operational complexity, be more flexible, and speed up operational decision-making at the frontline. It will help us to stay close to front-line employees and be more attentive to their needs and development," said Lee.

          Currently, the central region accounts for 45 percent of the company's business in China. The southern operations make up 35 percent, and the western region 20 percent. "We believe the western region will grow faster than the others," said the managing director.

          Related readings:
          Bayer HealthCare relocates China to be 3rd largest pharma market in 2011
          Bayer HealthCare relocates China lures global drug makers
          Bayer HealthCare relocates Chinese pharma sales to boost global demand
          Bayer HealthCare relocates Lilly to continue China expansion

          The company will also strengthen its sales force by adding 1,000 positions in 2011 in its core markets and lower-tier cities.

          Despite the current enthusiasm of multinational companies for merging or acquiring local counterparts, Lee said that "at the moment" the company is "focusing on organic expansion".

          But when there are good opportunities, the company will engage in mergers and acquisitions, he added.

          "It is a sort of shortcut for the multinationals to expand their product portfolios, obtain medicines tailored for local requirements and penetrate the grassroots market," said Guo Fanli, an analyst at the China Investment Consulting.

          In the "On-The-Counter" market, BHC paid 100 million euros ($141 million) for the cough and cold medicines portfolio of the domestic drugmaker Topsun Science and Technology Co Ltd in 2006.

           

          分享按鈕
          主站蜘蛛池模板: 日韩av在线一区二区三区| 99久久免费精品国产色| 免费夜色污私人影院在线观看| a毛片在线看片免费看| 国产精品中文字幕视频| 欧美 国产 亚洲 卡通 综合| 亚洲综合色网一区二区三区| 久久日韩在线观看视频| 国产亚洲精品久久综合阿香| 国产国产久热这里只有精品| 亚洲中文字幕无码专区| 久久96热在精品国产高清| 伊人精品无码AV一区二区三区| 午夜射精日本三级| 亚洲欧美啪啪视屏| 日本九州不卡久久精品一区| 免费A级毛片无码A∨蜜芽试看| 国产色婷婷亚洲99精品小说| 国产愉拍91九色国产愉拍| 曰韩无码二三区中文字幕| 精品午夜福利在线观看| 久久精品夜夜夜夜夜久久| 亚洲一本二区偷拍精品| 免费在线成人网| 少妇人妻偷人精品系列| 91国语精品3p在线观看| 91亚洲精品一区二区三区| 在线精品亚洲一区二区绿巨人| 又粗又爽高潮午夜免费视频| 成av人片一区二区久久| av无码东京热亚洲男人的天堂 | 亚洲乱码中文字幕小综合| 国产福利深夜在线播放| 男女猛烈激情xx00免费视频| 国色天香成人一区二区| 给我免费观看片在线| 亚洲国产精品丝袜在线观看| 人妻系列无码专区无码专区| 国产精品白浆免费视频| 国产稚嫩高中生呻吟激情在线视频| 国产高清免费午夜在线视频|